CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005394
NCT00005394N/ACompleted
CompareCT.gov

Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension

National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated May 13, 2016

In Brief

An observational study for Cardiovascular Diseases and 2 related conditions. Completed.

Detailed Summary

To identify and study a large cohort of glucocorticoid remediable aldosteronism (GRA) patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Hypertension, Heart Diseases
Countries--
Collaborators--

Timeline

N/ACompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartAug 1, 1995
Study CompletionJul 1, 2000
TodayJul 2, 2026
Posted 26.1 years ago